Hypogonadism
Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
Subtype terms (4)
More specific conditions that are subtypes of Hypogonadism in the MeSH hierarchy.
- Eunuchism
10 drugs (8 approved, 2 experimental)
- Kallmann Syndrome
12 drugs (7 approved, 5 experimental)
- Klinefelter Syndrome
10 drugs (8 approved, 2 experimental)
- Sexual Infantilism
Drugs by status
Approved for this indication (11)
Phase 4 trials (14)
Phase 3 trials (7)
Phase 2 trials (15)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (53)
- AbbVie
- Acerus Pharmaceuticals Corporation
- Merck Serono
- Eli Lilly
- Genentech
- Allergan
- Bayer
- Clarus Therapeutics, Inc.
- GlaxoSmithKline
- Sponsor GmbH
- Solvay
- Upsher-Smith Laboratories
- North Florida Foundation for Research and Education
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute on Aging (NIA)
- University of Roma La Sapienza
- Odense University Hospital
- Huazhong University of Science and Technology
- Medical University of Graz
- Barnsley Hospital
- Baylor University
- Boston University
- Brown University
- Chulalongkorn University
- Harvard University
- Diabetes Center of the Southwest
- University of Washington
- Johns Hopkins University
- Mahidol University
- McGuire Research Institute
- +23 more
Organization Involved with Phase 3 Indications (59)
- PPD
- Abbott
- ProStraken
- Merck
- Merck KGaA
- Ardana Bioscience Ltd
- Antares Pharma Inc.
- INC Research
- Lipocine Inc.
- Marius Pharmaceuticals
- PharmaNet
- Swiss National Science Foundation
- University Hospital, Basel, Switzerland
- SELARL du Dr Jacques BUVAT
- Dr. August Wolff GmbH & Co. KG Arzneimittel
- University of Pittsburgh
- Los Angeles Biomedical Research Institute
- Rijnstate Hospital
- Russian Academy of Medical Sciences
- Texas Tech University
- Tufts University
- Unita Complessa di Ostetricia e Ginecologia
- Universidad Complutense de Madrid
- University of Leeds
- University of Plymouth
- University of Tampere
- University of Bern
- University of Zurich
- Austin Health
- Kantonsspital Aarau
- +29 more
Organization Involved with Phase 2 Indications (40)
- Takeda
- AstraZeneca
- Unimed Pharmaceuticals
- Novartis
- M et P Pharma
- Mereo BioPharma
- Transdermal Delivery Solutions Corp
- TesoRx Pharma, LLC
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institutes of Health (NIH)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- University of Pennsylvania
- Albany Medical College
- Cornell University
- San Diego Sexual Medicine
- Sheffield Hallam University
- University of Florida
- University of Southern California
- Yale University
- St. Louis University
- State University of New York
- University of Modena and Reggio Emilia
- Celerion
- Faculdade de Medicina da USP
- Urology Group of Southern California
- Watson Pharmaceuticals
- University of Sao Paulo
- Hormos Medical
- Alabama Clinical Therapeutics
- PRACS
- +10 more
Organization Involved with Phase 1 Indications (19)
- Pfizer
- Diurnal Limited
- Chong Kun Dang Pharmaceutical
- Korea University
- University of Glasgow
- University of Manchester
- Mayo Clinic
- Cha Medical University
- University of Texas, Galveston
- AMPHA B.V.
- ARUP Laboratories
- Emas Pharma Ltd.
- Voet Consulting
- Brush Clinical Research Ltd.
- Envigo Pharma Consulting Limited
- Medical Matters International
- The University of Texas, Dallas
- Simbec-Orion
- Jeonbuk National University
Organization Involved with Other Experimental Indications (12)
- Chemical Resources
- Aarhus University
- Cedars-Sinai Medical Center
- Centro Riproduzione e Andrologia
- King George's Medical University
- University Hospital of North Norway
- University of Valencia
- University of Chicago
- University of Colorado, Denver
- Tsinghua University
- University of Illinois at Chicago
- American Federation for Aging Research